FDA Inspection 1053801 — Dayton Childrens Hospital

Dayton Childrens Hospital — FEI 1570986

The FDA completed an inspection of Dayton Childrens Hospital on May 15, 2018 in Dayton, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 15, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dayton, OH (United States)